Phase I First-in-Human Dose Escalation Study of the oral Casein Kinase 1α and Cyclin Dependent Kinase 7/9 inhibitor BTX-A51 in advanced MDS and AML
用户MiTCsb6qQkVQ
1个月前
54
10
已完结
1. 系统已在2026-01-26 10:47:26对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.21203/rs.3.rs-4954060/v1
文献链接: https://www.researchsquare.com/article/rs-4954060/v1
其他信息:
出版社: Springer Science and Business Media LLC
作者: Brian Ball; Wenbin Xiao; Gautam Borthakur; Le Xuan Truong Nguyen; Melissa Valerio; Avanthika Venkatachalam; Guido Marcucci; Anthony Stein; Dung Luong Thai; David Cook; Kyle Chan; Sonali Persaud; Ross Levine; Omar Abdel-Wahab; Yinon Ben-Neriah; Eytan Stein
